[Rapid progression of hypertrophic cardiomyopathy into a dilated form--unusual course in a young patient. A case

J Riedel1, U Neudorf, A A Schmaltz

  • 1Abteilung für Pädiatrische Kardiologie, Universitätsklinikum-GHS, Essen.

Zeitschrift Fur Kardiologie
|June 1, 1997
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) can progress to a dilative form with severe cardiac failure in adolescents. This case highlights the importance of monitoring HCM patients for potential progression to dilated cardiomyopathy.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatrics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a myocardial disorder characterized by left ventricular hypertrophy with preserved systolic function but impaired diastolic relaxation.
  • Sudden cardiac death is a primary complication of HCM, particularly in childhood, contributing to significant mortality.
  • While often asymptomatic, some HCM cases can progress to a dilated form over time.

Observation:

  • A twelve-year-old boy was diagnosed with hypertrophic cardiomyopathy.
  • Initially stable, his condition progressed by age sixteen to a dilative cardiomyopathy.
  • This progression resulted in reduced systolic function and severe cardiac failure.

Findings:

  • The case illustrates a rare but significant progression of hypertrophic cardiomyopathy to dilated cardiomyopathy in an adolescent.
  • The patient experienced a transition from preserved to reduced systolic function.
  • Severe cardiac failure developed following the progression of the disease.

Implications:

  • This case underscores the need for long-term monitoring of pediatric patients with hypertrophic cardiomyopathy.
  • Understanding the pathogenesis of HCM progression to dilated forms is crucial for early intervention.
  • Further research into the transition mechanisms may improve clinical outcomes and management strategies for affected children.

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...